Clinical trial
Study to Assess Safety and Efficacy of AQUAVAN® Injection for Sedation During…
NCT00209547 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00209547 |
|---|---|
| Title | Study to Assess Safety and Efficacy of AQUAVAN® Injection for Sedation During Cardiac Catheterization |
| Official title | A Phase III, Randomized, Open-Label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Percutaneous Coronary (PC) Procedures |
| Lead sponsor | Eisai Inc., Industry |
| Collaborators | PPD Development, LP Industry Covance |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Angioplasty, Coronary Catheterization |
| Intervention type | Drug |
| Interventions | fospropofol disodium |
| Enrollment | 110 |
| Start date | Feb 1, 2004 |
| Completion | Mar 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 7, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: